SCHEMBL4035810

SCHEMBL4035810

c1ccc(COc2ccc3ncccc3c2)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.77
ALOX5 P09917 1/20 0.67
NPC1 O15118 3/20 0.60
RAB9A P51151 3/20 0.60
PDE10A Q9Y233 1/20 0.52
MET P08581 1/20 0.51
IP6K1 Q92551 1/20 0.49
POLB P06746 1/20 0.49
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
HSP90AA1 P07900 1/20 0.48
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA7 P43166 1/20 0.48
CA9 Q16790 1/20 0.48
ALDH1A1 P00352 1/20 0.48
MRGPRX4 Q96LA9 1/20 0.48
LCK P06239 1/20 0.48
STAT3 P40763 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1681256 0.97 CYP3A4 (0.73) CYP3A4ALOX5NPC1RAB9APDE10A
SCHEMBL13463310 0.94 CYP3A4 (0.69) CYP3A4ALOX5NPC1RAB9APDE10A
SCHEMBL18154063 0.88 CYP3A4 (0.64) CYP3A4ALOX5NPC1RAB9APDE10A
SCHEMBL30125417 0.87 CYP3A4 (1.00) CYP3A4ALOX5NPC1RAB9APDE10A
SCHEMBL841728 0.87 CYP3A4 (1.00) CYP3A4ALOX5NPC1RAB9APDE10A
SCHEMBL13463295 0.86 CYP3A4 (0.58) CYP3A4ALOX5NPC1RAB9APOLB
SCHEMBL13463408 0.86 CYP3A4 (0.58) CYP3A4ALOX5NPC1RAB9AALDH1A1
SCHEMBL13463305 0.85 CYP3A4 (0.57) CYP3A4ALOX5RAB9AMEN1KMT2A
SCHEMBL13463304 0.84 CYP3A4 (0.56) CYP3A4
SCHEMBL10653042 0.84 CYP3A4 (0.56) CYP3A4ALOX5NPC1RAB9APDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020063854-A1 QUINOLINE-BASED DERIVATIVES AS VAP-1 INHIBITORS 南京明德新药研发有限公司 2020-04-02 WO disclosed
CN-104250252-A Pyrazolo[1,5-a]miazine compound and its preparation method and medical use SHANGHAI JIESEN PHARMACEUTICAL CHEMISTRY TECHNOLOGY CO LTD 2014-12-31 CN disclosed
EP-2029572-A2 ORGANIC COMPOUNDS Novartis AG (CH) 2009-03-04 EP disclosed
WO-2007143597-A2 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2007-12-13 WO disclosed
EP-1724268-A1 COMPOUND HAVING TGF-BETA INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME KIRIN BEER KABUSHIKI KAISHA (JP) 2006-11-22 EP disclosed
EP-0138773-B1 USE OF QUINOLINE DERIVATIVES FOR THE PROTECTION OF CROP PLANTS CIBA-GEIGY AG (CH) 1990-08-29 EP disclosed